REVERE PHARMACEUTICALS
Revere Pharmaceuticals is an oncology-focused biotechnology company leading the development of small molecule therapeutics targeting Rac1 signaling for cancers with unmet clinical needs. Rac1 activity is a key driver of metastatic progression and drug resistance in diverse cancer types. Revere’s lead Rac1 targeted drug candidate is REV-440. The successful development of REV-440 has the potential to provide meaningful clinical impact in multiple refractory cancers characterized by aberrant Rac... 1 signaling. Revere expects REV-440 to enter clinical trials in 2021. Initial clinical development of REV-440 will focus on recurrent ovarian cancer and the critical unmet clinical need of platinum-resistant disease. Treatment of ovarian cancer with REV-440 is supported by compelling preclinical efficacy data. The company was founded in 2016.
REVERE PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Arlington, Massachusetts, United States
Country:
United States
Website Url:
http://www.reverepharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 781 718 9033
Email Addresses:
[email protected]
Total Funding:
4.51 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Nginx
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Employees Featured
Founder
Official Site Inspections
http://www.reverepharma.com
- Host name: 148.157.199.35.bc.googleusercontent.com
- IP address: 35.199.157.148
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Revere Pharmaceuticals"
Small Molecule Therapeutics | About Us - Revere …
Revere Pharmaceuticals is headquartered in Boston and conducts research in our San Diego laboratory, supported by a network of research partners in the U.S., Canada, and India. Revere Pharmaceuticals is developing small …See details»
Revere Pharmaceuticals | Precision Medicine | Rac1 GTPase Protein
Revere Pharmaceuticals is advancing precision medicine to address unmet needs in cancer and other diseases by targeting Rac1 GTPase proteins.See details»
Revere Pharmaceuticals - Crunchbase Company Profile & Funding
Revere Pharmaceuticals develops a drug discovery and development platform targeting Rac1 and its genomic variants. View contacts for Revere Pharmaceuticals to access new leads and …See details»
Revere Pharmaceuticals | Rac1 GTPase Research | Contact Us
Revere Pharmaceuticals is advancing precision medicine by targeting Rac1 GTPase proteins. Find contact info and learn more.See details»
Revere Pharmaceuticals - LinkedIn
Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rho GTPases, which play a key role in the progression of many cancers. Our...See details»
Revere Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Revere Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Revere Pharmaceuticals Inc.
- https://reverepharma.com. Metrics Founded 2016 Employees Range 1-10 Number of Employees 5 Estimated Annual Revenue $0-$1M EIN Number 814687513 ... Phone numbers associated …See details»
Revere Pharmaceuticals - Overview, News & Similar companies
View Revere Pharmaceuticals (www.reverepharma.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Revere Pharmaceuticals - VentureRadar
Website: https://reverepharma.com/ Develops small molecule drugs targeting Rac1 and its genomic variants for treatment of various diseases including cancers, Alzheimer's, and COVID …See details»
Revere Pharmaceuticals | CipherBio
Revere Pharmaceuticals is a Boston-based startup leading the way in the development of new cancer treatments targeting Rac1 GTPase, an important target in the progression of different …See details»
Revere Pharmaceuticals, Inc. (Revere Pharmaceuticals, Inc.) - 药物 …
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。 立即开始数据试用! 智慧芽新药库数据也通过智慧芽数据服务平台， …See details»
Revere Pharmaceuticals - Products, Competitors, Financials, …
Revere Pharmaceuticals focuses on the development of new cancer treatments within the biopharmaceutical industry. The company offers a suite of proprietary biochemical and cell …See details»
Small Molecule Therapeutics | Our Platform - Revere …
Revere Pharma has developed an innovative drug discovery and development platform that drives our small molecule pipeline targeting Rac1 and its genomic variants. We have …See details»
Revere Pharmaceuticals Company Profile -Sales, Contacts, …
Revere Pharmaceuticals is in the Proprietary Drug Products industry within the Chemicals and Allied Products sector and has been in business for approximately 8 years.See details»
Revere Pharmaceuticals – Funding, Valuation, Investors, News
Https://reverepharma.com/ Tags: BioTech Development Drug HealthTech Manufacturing Medtech Platform Revere Pharmaceuticals is a Boston-based startup leading the way in the …See details»
Revumenib - Wikipedia
Revumenib, sold under the brand name Revuforj, is an anti-cancer medication used for the treatment of acute leukemias harboring lysine methyltransferase 2A gene (KMT2A) …See details»
Privacy Policy - Revere Pharmaceuticals
Effective November 15, 2021. This Privacy Policy describes how Revere Pharmaceuticals, Inc. (“we” or “Revere”) collects, uses, discloses and otherwise processes information about you …See details»
Smart Justice - Lessons From The United States To Address …
Today, the IPA has released Smart Justice: Lessons from the United States to address Australia’s emerging incarceration crisis, a monograph explaining our analysis of successful criminal …See details»
Revere Pharmaceuticals Expands Board of Directors to Include …
Feb 22, 2021 · Boston, Mass. — Revere Pharmaceuticals, an emerging biopharmaceutical company developing small molecule drugs targeting the Ras-homologous (Rho) family …See details»
Small Molecule Therapeutics | Our News - Revere Pharmaceuticals
Stay up to date on new developments from Revere Pharmaceuticals and our pipeline of novel, small molecule therapeutics for cancer targeting the Rac1 GTPase.See details»